Health and Human Services News and Research

RSS

Synergenz awarded $94,836 research grant under federal QTDP program

Synergenz BioScience, Inc., a leader in predictive risk stratification for smoking-related lung cancer, was awarded a research grant under the Federal Government's Qualifying Therapeutic Discovery Project (QTDP) program.

3 Nov 2010

OncoMed receives $1.2 million to support therapeutic programs under QTDP program

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.

3 Nov 2010

Neoprobe receives $244,479 grant under QTDP program

Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.

3 Nov 2010

BioCryst receives $1.1 million in grants under QTDP program

BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.

3 Nov 2010

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

Enzon Pharmaceuticals, Inc. today announced that it has been awarded $1.2 million in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program, which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010.

3 Nov 2010

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

3 Nov 2010

Decisions on health law's fate start today as GOP seems poised for gains

Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious but not outright stop the law.

3 Nov 2010

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.

3 Nov 2010

Inviragen receives two grants to develop dengue and chikungunya vaccines

Inviragen, a biotechnology company developing vaccines to protect against infectious diseases worldwide, announced today that it has received two grants totaling $488,958 through the United States government's Qualifying Therapeutic Discovery Project Program.

3 Nov 2010

Pain Therapeutics awarded $2,000,000 U.S. government research grant

Pain Therapeutics, Inc. announced today that it has been awarded over $2,000,000 in research grants by the U.S. government. These grants are planned to support the Company's on-going biomedical research for nervous system disorders and oncology. Pain Therapeutics expects to receive funding from these research grants now through the end of 2011.

2 Nov 2010

IRS awards RXi Pharmaceuticals four Therapeutic Discovery Project grants

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded four Therapeutic Discovery Project (TDP) grants, totaling $977,917, by the United States Internal Revenue Service (IRS) as part of the Patient Protection and Affordable Care Act of 2010.

2 Nov 2010

House win would give GOP the ways, means to roll back health law

A GOP takeover of the House would give Republicans the ability to attack the new law in new ways. If Rep. Joe Barton becomes chairman of the House Energy and Commerce Committee next year, the Texas Republican vows to make life miserable for Democratic defenders of the health care overhaul law.

2 Nov 2010

HHS awards CTI $977,917 in grants under Therapeutic Discovery Tax Credit program

Cell Therapeutics, Inc. today announced that it has been awarded $977,917 in grants under the Therapeutic Discovery Tax Credit program that was enacted under the U.S. government's Patient Protection and Affordable Care Act. The program targets projects that show potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer.

2 Nov 2010

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.

2 Nov 2010

Health law, elections trigger questions about Medicare payment issues

While most people are focused on the midterm elections Tuesday, the American Medical Association is gearing up for the lame-duck congressional session scheduled to start Nov. 15.

2 Nov 2010

AHRQ: Hospital admissions for adverse drug reactions have doubled

News outlets report on the hospital industry, including admission rates, mergers and quality improvement programs.

1 Nov 2010

HHS announces 'Early Innovators' grants for states to implement IT for health insurance exchanges

The U.S. Department of Health and Human Services (HHS) today announced competitive funding opportunities for states to design and implement the information technology (IT) infrastructure needed to operate health insurance exchanges. The exchanges represent new competitive insurance marketplaces that will help Americans and small businesses purchase affordable private health insurance starting in 2014 and a strong IT infrastructure will be critical to their success.

30 Oct 2010

Third summit on health care fraud prevention commences on 5th November

On Friday, November 5, Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will kick-off the third in a series of day-long summits bringing together a wide-array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system.

30 Oct 2010

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

BioMedix announced today that TRAKnet Practice Management Software 2.0 is 2011/2012 compliant and was certified as a Complete EHR on October 28th, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services.

30 Oct 2010

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

The federal Department of Health and Human Services is still accepting applications for the $5 billion program to help cover the cost of retiree health care, the National Journal reports. The agency says 700 more employers have joined the program, raising the total to 3,600.

30 Oct 2010

Health and Human Services News and Research

Synergenz awarded $94,836 research grant under federal QTDP program

OncoMed receives $1.2 million to support therapeutic programs under QTDP program

Neoprobe receives $244,479 grant under QTDP program

BioCryst receives $1.1 million in grants under QTDP program

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

Somaxon awarded $245,000 grant for Silenor under QTDP program

Decisions on health law's fate start today as GOP seems poised for gains

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

Inviragen receives two grants to develop dengue and chikungunya vaccines

Pain Therapeutics awarded $2,000,000 U.S. government research grant

IRS awards RXi Pharmaceuticals four Therapeutic Discovery Project grants

House win would give GOP the ways, means to roll back health law

HHS awards CTI $977,917 in grants under Therapeutic Discovery Tax Credit program

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

Health law, elections trigger questions about Medicare payment issues

AHRQ: Hospital admissions for adverse drug reactions have doubled

HHS announces 'Early Innovators' grants for states to implement IT for health insurance exchanges

Third summit on health care fraud prevention commences on 5th November

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News